Literature DB >> 34724106

Clinical and oncological benefits of left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma.

Yoshitsugu Nakanishi1, Satoshi Hirano2, Keisuke Okamura2, Takahiro Tsuchikawa2, Toru Nakamura2, Takehiro Noji2, Toshimichi Asano2, Aya Matsui2, Kimitaka Tanaka2, Soichi Murakami2, Yuma Ebihara2, Yo Kurashima2, Yusuke Watanabe2, Toshiaki Shichinohe2.   

Abstract

PURPOSE: This retrospective study aimed to clarify whether the postoperative prognosis differs between right and left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma.
METHODS: Preoperative images of 195 patients with perihilar cholangiocarcinoma were reexamined. Patients with Bismuth type I/II perihilar cholangiocarcinoma without a difference in extraductal tumor invasion between the right and left sides of the hepatic portal region were classified into those undergoing left (L group) or right (R group) hepatectomy.
RESULTS: Twenty-three patients (11.8%) were classified into the L group and 33 (16.9%) into the R group. All eight patients with pTis/1 belonged to the L group. The L group had significantly less liver failure than the R group (p = 0.001). One patient (4.3%) in the L group and four patients (12.1%) in the R group died from postoperative complications. Among 48 patients with pT2, the L group tended to have better overall survival (median, 12.2 vs. 5.6 years; p = 0.072), but not recurrence-free survival (median, 9.1 vs. 3.6 years; p = 0.477), in comparison to the R group.
CONCLUSIONS: Postoperative survival after left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma is expected to be as long as that after right hepatectomy.
© 2021. The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Bismuth classification; Left hepatectomy; Perihilar cholangiocarcinoma; Prognosis

Mesh:

Substances:

Year:  2021        PMID: 34724106     DOI: 10.1007/s00595-021-02401-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  4 in total

1.  Ethical perspectives on the Japanese guidelines for cadaver surgical training (CST).

Authors:  Yasuhiro Kadooka
Journal:  Anat Sci Int       Date:  2022-05-09       Impact factor: 1.741

Review 2.  Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review.

Authors:  Takehiro Noji; Satoshi Hirano; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

3.  Bacteremia after hepatectomy and biliary reconstruction for biliary cancer: the characteristics of bacteremia according to occurrence time and associated complications.

Authors:  Junki Fukuda; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Takehiro Noji; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  Surg Today       Date:  2022-02-02       Impact factor: 2.540

4.  Usage of cadavers in surgical training and research in Japan over the past decade.

Authors:  Toshiaki Shichinohe; Hiroshi Date; Satoshi Hirano; Eiji Kobayashi; Yoshimitsu Izawa; Yasuhiro Shirakawa; Masako Hiramatsu; Mitsuhito Mase; Hiroshi Taneichi; Hiroyuki Yaginuma; Toyoshi Fujimoto; Toshiyuki Tsurumoto; Masahiko Watanabe; Hiroshi Kurita; Naohito Hato; Tomoyasu Kato; Hiroomi Kanayama; Takane Suzuki; Kumiko Yamaguchi; Yoshimasa Takeda
Journal:  Anat Sci Int       Date:  2022-04-05       Impact factor: 1.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.